SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-20-002397
Filing Date
2020-02-05
Accepted
2020-02-05 16:42:38
Documents
17
Period of Report
2019-11-20
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K/A form8ka.htm   iXBRL 8-K/A 53237
2 CONSENT OF KPMG LLP ex23_1.htm EX-23.1 5216
3 HISTORICAL AUDITED CONSOLIDATED FINANCIAL STATEMENTS AND FINANCIAL STATEMENT SCH ex99_1.htm EX-99.1 2778161
4 UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF CELGENE CORPORATION AND ex99_2.htm EX-99.2 2102751
5 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF BRISTOL-MYERS SQ ex99_3.htm EX-99.3 1322577
  Complete submission text file 0001140361-20-002397.txt   6906733

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bmy-20191120.xsd EX-101.SCH 5262
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20191120_def.xml EX-101.DEF 19568
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20191120_lab.xml EX-101.LAB 30331
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20191120_pre.xml EX-101.PRE 21982
11 EXTRACTED XBRL INSTANCE DOCUMENT form8ka_htm.xml XML 9864
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-01136 | Film No.: 20579355
SIC: 2834 Pharmaceutical Preparations